Search

everythinglearnresearchcommunity

for

Search:↓

Two new enzymes, PAD-R11 and PAD-R4, were cloned and showed activity, with PAD-R11 resembling epidermal enzymes.

Some new progesterone derivatives are better at blocking testosterone conversion than a common drug.

Using 5-α-reductase inhibitors before treatment improves outcomes for patients with metastatic renal cell carcinoma.

Peginterferon alpha-2a effectively treats acute hepatitis C in hemodialysed patients, despite some side effects.

Upadacitinib can effectively regrow hair in alopecia areata patients without worsening sarcoidosis.

Reducing reactive oxygen species can help treat nerve damage from platinum cancer drugs.

Pioglitazone may help treat lichen planopilaris, but more research is needed.

Some medications for inflammation can cause a condition with scalp rashes and hair loss, often linked to Crohn's disease, and may require treatment changes to prevent permanent hair loss.

The treatment was effective for lupus nephritis with manageable side effects.

Combining α1-blockers with 5α-reductase inhibitors improves urinary symptoms in men.

5α-reductase inhibitors don't stop bladder cancer from developing or getting worse.

Medicines called 5-alpha-reductase inhibitors, like finasteride and dutasteride, are useful for treating enlarged prostate and male pattern hair loss.

Upadacitinib successfully treated a child's severe skin and hair loss issues.

Too much AKR1C3 enzyme causes resistance to finasteride by increasing testosterone.

Steroidogenesis inhibitors change but don't stop androgen production in prostate cancer.

Farudodstat may effectively treat alopecia areata by protecting hair follicles without harmful effects.

JAK inhibitors show promise for treating skin diseases effectively and safely.

Baricitinib is effective and safe for long-term use in severe alopecia areata, improving hair regrowth and quality of life with few side effects.

Baricitinib was effective in regrowing eyebrow and eyelash hair in patients with severe alopecia areata.

TNF-alpha inhibitors can cause various immune-related skin issues.

A Korean woman with complete hair loss regrew her hair after taking tofacitinib, with no side effects.

Mirvetuximab soravtansine improves quality of life and reduces symptoms more than standard chemotherapy in ovarian cancer patients.

A medicine company has recalled a drug because it contained an unlisted blood pressure medication.

Different drugs for prostate-related urinary symptoms work but have various side effects, and treatment should be tailored to the individual.

Certain Dibenzo derivatives may help treat prostate cancer.

The compound 4c showed strong potential as an anticancer agent.

Adalimumab significantly improves quality of life for patients with moderate to severe hidradenitis suppurativa.

CT-707 is effective and safe for treating certain Chinese lung cancer patients.

A cholesterol-free liposomal platform using protopanaxadiol effectively promotes hair growth and treats alopecia.

Reducing gefitinib dosage improved hair loss, but scarring remained.